DEF 14A

Company

Entera Bio Ltd.

Filed

June 5, 2025

Period of Report

June 5, 2025

Accession Number

0001178913-25-002111

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →